Inspire Medical Systems, Inc. INSP
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-05-03
Inspire Medical Systems, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 85.4% | 84.7% | 84.5% | 83.8% | 85.7% |
| Operating margin | 5.6% | 4.5% | -6.4% | -11.7% | -17.1% |
| Net margin | 15.9% | 6.7% | -3.4% | -11.0% | -18.0% |
| FCF margin | 8.6% | 11.4% | 0.2% | 0.6% | -10.6% |
| Return on assets | 16.0% | 6.6% | -3.1% | -7.9% | -14.2% |
| Return on equity | 18.6% | 7.8% | -3.7% | -9.0% | -18.4% |
| Debt / equity | — | — | — | — | 0.11× |
| Current ratio | 6.08 | 7.13 | 7.60 | 8.66 | 6.50 |
| Revenue growth | 13.6% | 28.5% | 53.2% | 74.7% | 102.3% |
Source: SEC EDGAR filings · CIK 0001609550 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.